These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 21983361

  • 1. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.
    Miller E, Andrews NJ, Waight PA, Slack MP, George RC.
    Vaccine; 2011 Nov 15; 29(49):9127-31. PubMed ID: 21983361
    [Abstract] [Full Text] [Related]

  • 2. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.
    Andrews NJ, Waight PA, George RC, Slack MP, Miller E.
    Vaccine; 2012 Nov 06; 30(48):6802-8. PubMed ID: 23000122
    [Abstract] [Full Text] [Related]

  • 3. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.
    Vaccine; 2013 Dec 16; 31(52):6232-8. PubMed ID: 24176490
    [Abstract] [Full Text] [Related]

  • 4. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ, McIntosh ED, Reinert RR.
    Int J Infect Dis; 2010 Mar 16; 14(3):e197-209. PubMed ID: 19700359
    [Abstract] [Full Text] [Related]

  • 5. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 Mar 12; 59(9):253-7. PubMed ID: 20224541
    [Abstract] [Full Text] [Related]

  • 6. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S, Menzies R, Chiu C, Toms C, Blyth CC, Krause V, McIntyre P.
    Clin Infect Dis; 2017 Jan 15; 64(2):175-183. PubMed ID: 27986682
    [Abstract] [Full Text] [Related]

  • 7. Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--2011.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Nov 04; 60(43):1477-81. PubMed ID: 22048728
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
    Andrews N, Kent A, Amin-Chowdhury Z, Sheppard C, Fry N, Ramsay M, Ladhani SN.
    Vaccine; 2019 Jul 26; 37(32):4491-4498. PubMed ID: 31272872
    [Abstract] [Full Text] [Related]

  • 9. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.
    Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249
    [Abstract] [Full Text] [Related]

  • 10. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
    American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 2010 Jul 15; 126(1):186-90. PubMed ID: 20498180
    [Abstract] [Full Text] [Related]

  • 11. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
    Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L, Catalan study group of invasive pneumococcal disease.
    J Infect; 2011 Aug 15; 63(2):151-62. PubMed ID: 21679725
    [Abstract] [Full Text] [Related]

  • 12. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MP, Harrison TG, Ladhani SN, Miller E.
    Vaccine; 2014 Jul 23; 32(34):4349-55. PubMed ID: 24657717
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.
    Ansaldi F, de Florentiis D, Canepa P, Zancolli M, Martini M, Orsi A, Durando P, Icardi G.
    Vaccine; 2012 Mar 16; 30(13):2288-94. PubMed ID: 22306795
    [Abstract] [Full Text] [Related]

  • 15. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.
    Gladstone RA, Jefferies JM, Faust SN, Clarke SC.
    Expert Rev Vaccines; 2012 Aug 16; 11(8):889-902. PubMed ID: 23002969
    [Abstract] [Full Text] [Related]

  • 16. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.
    Pediatr Infect Dis J; 2007 Sep 16; 26(9):771-7. PubMed ID: 17721369
    [Abstract] [Full Text] [Related]

  • 17. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
    van der Linden M, Weiß S, Falkenhorst G, Siedler A, Imöhl M, von Kries R.
    Vaccine; 2012 Aug 31; 30(40):5880-5. PubMed ID: 22771186
    [Abstract] [Full Text] [Related]

  • 18. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E.
    Lancet Infect Dis; 2015 May 31; 15(5):535-43. PubMed ID: 25801458
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R.
    Pediatr Infect Dis J; 2009 Apr 31; 28(4):277-82. PubMed ID: 19258924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.